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Abstract
Background Both long and short cephalomedullary nails
(CMN) may be used to treat trochanteric femur fractures.
The objective of this paper was to compare the clinical
outcomes between long and short CMN in the treatment of
trochanteric hip fractures.
Materials and methods A literature search was per-
formed, identifying 135 papers; 4 of which met inclusion
and exclusion criteria. Papers included were those that
compared cohorts of long and short nails for
stable trochanteric femur fractures of level III evidence or
superior. Data was pooled and analyzed, focusing on
reoperation rate, secondary femoral shaft fracture rate,
estimated blood loss, transfusion rate, operative time and
length of stay.
Results Included in the analysis were 1276 patients, with
438 short and 838 long CMN. The average age was
82.0 years for short CMN and 79.0 years for long CMN
(P = 0.0002). The average follow up was 18 months,
46 % were male, and 71 % had an ASA (American Society
of Anesthesiologists score) classification C3. The rate of
reoperation was 5.0 % and 3.8 % for short and long CMN,
respectively (P = 0.31). The rate of refracture was 1.6 %
and 0.95 % for short and long CMN, respectively
(P = 0.41). As compared to long nails, short nails had an
average blood loss of 39 mL less (P = 0.0003), an 8.8 %
decrease in transfusion rate (P = 0.07), and incurred
19 min less operative time (P\ 0.0001). No significant
differences between short and long nails were observed for
either other complications, hardware complications, non-
union, or mortality.
Conclusions For trochanteric femur fractures, short CMN
have a low reoperation rate while significantly decreasing
operative time and estimated blood loss with the additional
benefit of being cost effective.
Level of evidence Level 3.
Keywords Hip fracture  Hospital cost 
Cephalomedullary nail  Reoperation
Introduction
The frequency of hip fractures is increasing steadily with
an aging and increasingly physical active population [1, 2].
It is estimated that by 2050, there will be 6.26 million hip
fractures world-wide annually. By the age of 80 years,
20 % of women will have sustained a hip fracture, and by
90 years, nearly 50 % of women will have had a hip
fracture [3]. Furthermore, the 1-year mortality for hip
fractures is roughly 20 % [4, 5].
Stable trochanteric femur fractures are most often fixed
by cephalomedullary nails (CMN) or sliding hip screws
(SHS). For stable fracture patterns, CMN has been shown
to be equivalent to SHS in terms of stability [6]. However,
the SHS construct has been found to provide inadequate
fixation in more unstable fractures types [7, 8], more often
leading to malreduction [9] and lag screw cut-out [10].
CMN have been increasingly favored as a more reliable
option for hip fracture fixation, and the utilization of CMN
is increasing [11], especially among younger surgeons [12].
Both short and long CMN are available options for hip
fracture fixation. Short nails offer the advantages of shorter
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operative times, reduced blood loss, and lower transfusion
rates [13, 14]. Conversely, long nails offer the theoretical
benefit of protecting the full length of the femur, particu-
larly in elderly patients with osteoporotic or osteopenic
bone, thus potentially decreasing secondary femoral shaft
refracture rates [15]. However, because of the limited
power of the individual retrospective comparative studies,
differences in rates of secondary femoral shaft refracture
reoperation have not been found to be significant [13, 14,
16, 17].
We hypothesize that by pooling data from all available
comparative cohorts regarding CMN fixation of extra-
capsular AO type 31A fractures, there will be no difference
in reoperation and secondary femoral shaft refracture rates
of short and long CMN. Furthermore, by conducting a
number needed to treat to harm and concomitant cost
analysis comparing the combined reoperation and sec-
ondary femoral shaft refracture rates of the short and long
CMN derived from our systematic review, we hypothesize
that short CMN are significantly more cost effective.
Materials and methods
The present study is reported following PRISMA guideli-
nes [18]. There was no source of funding or support for this
analysis.
Eligibility
The inclusion criteria for the present analysis comprised
papers that (1) reviewed results of treatment of patients
with simple or multifragmentary intertrochanteric femur
fractures (31-A1, A2, and A3); (2) compared results from
patients treated with long CMN versus short CMN fixation;
(3) followed patients for a minimum of 1 year; and (4)
included description and rate of reoperation and peripros-
thetic fracture. Only studies written in the English language
were considered.
Studies were excluded if they (1) did not include both
short and long CMN cohorts; or (2) had less than 1 year
follow up. One paper [16] included fractures other than the
31A type. In this analysis, all non-31A fractures (113
fractures from the study by Vaughn et al. [16]) and the
respective data were excluded from the present analysis.
Outcomes
The primary outcome measures were the rates of (1)
reoperation, (2) periprosthetic fracture, and (3) mortality.
We additionally isolated reoperation due to nonseptic
failure as well as reoperation due to mechanical failures
alone. Nonseptic failures excluded infection as a cause for
revision. Mechanical failures included failures of the
implant, such as screw cut-out, loosening, fixation failure,
and prominent screws, excluding revision for pain without
implant failure. The secondary outcome measures were (1)
blood loss, (2) number of RBC units transfused, (3) number
of patients transfused, (4) operative time, (5) length of
hospital stay, (6) nonunion, and (7) complications. We
isolated complications other than periprosthetic fracture as
well as hardware complications specifically. Demographic
data were also collected and pooled.
Search strategy and selection of studies
A systematic search was performed for all articles pub-
lished on the treatment of intertrochanteric femur fractures
with cephalomedullary fixation using the PubMed, Med-
line, EMBASE, and Cochrane databases between the years
1990 and 2015. Search terms included, cephal-
lomedullary*, intertroch*, trochanteric fracture nail*,
extracapsular fracture*, short*, and long*.
The abstracts generated by the search were individually
assessed for relevance by two senior authors (B.R.W. and
P.J.B.). Full manuscripts of individual studies were then
thoroughly reviewed independently according to the
inclusion and exclusion criteria. If the data was not
explicitly stated in the manuscript, the corresponding
author was contacted for further information. Any dis-
agreements or discrepancies in study selection were mod-
erated by consensus.
Assessment of methodological quality and data
collection
The GRADE (Grading of Recommendations Assessment,
Development and Evaluation Working Group) criteria are a
quality assessment template used to evaluate the quality of
methods in study analysis [19]. Using this template, the
quality of the selected studies was independently assessed
by the two senior authors (B.R.W. and P.J.B.). Disagree-
ment concerning study quality was moderated by consen-
sus. For all previously identified studies deemed eligible,
the authors extracted pertinent data.
Data pooling across studies and data analysis
Demographic data, primary outcome measures, and sec-
ondary outcome measures from comparable studies were
pooled for all patients, those receiving a short CMN, and
those receiving a long CMN. None of the studies received
external funding and no clear sources of bias were identi-
fied. Outcome measures were compiled and compared.
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Statistical analysis
Continuous variables were compared with use of the Stu-
dent t test, and categorical data were compared with use of
either the Fisher exact test or the Chi square test. A P value
of\ 0.05 was considered significant. Analyses were per-
formed using SAS version 9.3 (SAS Institute, Cary, NC).
A number needed to harm analysis was conducted given
the absolute risk reduction in both refracture and reopera-
tion between the short and long CMN cohorts. Further-
more, we performed a post hoc power analysis given the
existing data to determine the sample size necessary to
produce statistical significance between the short and long
CMN cohorts with respect to both refracture and
reoperation.
Results
The search resulted in 135 potentially eligible studies,
while only 4 met inclusion and exclusion criteria (Fig. 1).
All studies were retrospective comparative cohorts, level
III therapeutic studies [13, 14, 16, 17] (Table 1). In total,
1179 patients, with 438 short and 838 long CMN, were
included. Patients were treated with one of the following
four CMN: Gamma 3 short (Stryker, Kalamazoo, MI),
gamma 2 and 3 long nails (Stryker), or Synthes Trocanteric
Fixation Nail short or long nail (Synthes, Paoli, PA). The
average age was 82.0 years and 79.0 years, for short and
long nails, respectively (P = 0.0002). The average follow-
up was 18 months, 46 % were male, and 71 % had an ASA
(American Society of Anesthesiologists score) classifica-
tion C3 (Table 1).
Outcome measure reporting
Intraoperative variables and hospital length of stay were
recorded (Table 2). Two studies reported estimated blood
loss, transfusion rates, and length of stay [13, 14]. The
average blood loss was 86.7 and 135.2 mL for short and
long CMN, respectively (P = 0.0003). The blood transfu-
sion rate was 41 % for short and 50 % for long CMN
(P = 0.07). The length of hospital stay was 7.0 and
7.3 days for short and long CMN, respectively (P = 0.48).
Three studies reported operative time [13, 14, 17]. The
mean operative time was 47.1 min for short CMN and
65.6 min for long CMN (P\ 0.0001).
All studies recorded reoperation, refracture, and other
complications (Table 3). The overall rate of reoperation
was 5.0 and 3.8 % for short and long CMN, respectively
(P = 0.31). The rate of reoperation due to non-septic
failure was 4.8 % for short and 3.3 % for long CMN
(P = 0.20) while that due to secondary to mechanical
failure was 3.7 % and 2.5 % for short and long CMN,
respectively (P = 0.25).
The rate of refracture was 1.60 % for short CMN and
0.95 % for long CMN (P = 0.31). The rate of other
complications was 4.6 % and 5.25 % for short and long
CMN, respectively (P = 0.57). There was no statistically
significant difference between short and long CMN for
other complications, hardware complications, non-union,
or mortality.
Fig. 1 Cohort inclusion and
exclusion
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Although the refracture and reoperation were not sta-
tistically significant between the two groups, a number
needed to harm was calculated as a worst case scenario.
The calculated number needed to treat to harm for refrac-
ture and all-cause reoperation for short over long CMN
were calculated to be 154 and 83, respectively.
The studies did not report mortality uniformly. Vaughn
et al. [16]. did not report mortality. In the study by Kle-
weno et al. [17], the authors found that 175 of 698 patients
died prior to 12-month follow up. These patients were
excluded from any further analysis. Similarly, Boone et al.
[13]. did not distinguish between short and long CMN
patient mortality but noted that 41 of 194 patients died
within 1year. Conversely, Hou et al. [14]. reported 9/58
short and 15/68 long CMN deaths within 1 year. While the
mortality rate between long and short CMN could not be
compared in this analysis, the pooled 1-year mortality rate
was 26.5 %.
Table 1 Demographics. ASA American Society of Anesthesiologists score,NR not reported
Author Fractures Follow-up
(months)
Male Age (years) ASA C3 OTA classification
(31A1/A2/A3)
Hou et al. [14] 283 37 73 79 171 126/157/0
100 short 81 59/41/0
183 long 78.6 67/116/0
Boone et al. [13] 194 12 54 81.1 NR 59/142/0
82 short 83.3 31/51/0
119 long 79.6 28/91/0
Vaughn et al. [16] 143 12 NR NR NR 36/79/28
37 short 11/19/7
106 long 25/60/21
Kleweno et al. [17] 559 12 349 84 426 NRa/NRa/143
219 short NR
430 long NR
a Reported 416 31A1/A2 fractures, combined
Table 2 Intraoperative
variables and hospital length of
stay
Short nail Long nail P value
Age, mean (SD) 82.0 (8.1) 79.0 (9.1) 0.0002
EBL (mL), mean (SD) 96.7 (67.2) 135.2 (139.7) 0.0003
RBC (units) 0.8166
1–2 37 (37.0 %) 68 (37.2 %)
3–5 4 (4.0 %) 10 (5.5 %)
[5 1 (1.0 %) 5 (2.7 %)
Patients transfused 75 (41.2 %) 151 (50.0 %) 0.0738
Operative time (min), mean (SD) 47.1 (18.4) 65.6 (32.5) \0.0001




Short nail Long nail P value
Reoperation 22 (5.02 %) 32 (3.82 %) 0.3103
Reoperation due to aseptic failure 21 (4.79 %) 28 (3.34 %) 0.1996
Reoperation due to mechanical failure 16 (3.65 %) 21 (2.51 %) 0.2463
Refracture 7 (1.60 %) 8 (0.95 %) 0.3112
Other complications 20 (4.57 %) 44 (5.25 %) 0.5949
Hardware complications 14 (3.20 %) 32 (3.82 %) 0.5713
Nonunion 1 (0.23 %) 5 (0.60 %) 0.3611
Mortality 22 (5.02 %) 42 (5.01 %) 0.9932
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Discussion
In this systematic review, there was a small but statistically
insignificant increase in all-cause reoperation and sec-
ondary femoral shaft refracture with short versus long
CMN in the setting of stable trochanteric femur fractures.
The current study only includes the most third generation
of the short CMN, including the Stryker Gamma 3 short
and Synthes Trochanteric Fixation Nail short, which have
been reported to have decreased rates of post-operative
secondary femoral shaft fractures [15]. An argument could
be made that the average 38.5 mL increase in estimated
blood loss and 18.5 min increase in operative time with
implantation of a long versus short CMN is not clinically
significant. However, the surgeon must consider the
increased cost associated with use of the long CMN.
The higher cost of the long CMN is most heavily
influenced by the increased operative time (Table 4). The
difference in operative time between the short and long
CMN is most likely attributed to additional time spent
reaming the canal for the long CMN, and the method of the
distal interlock screw insertion. The cost of running the
operating room depends on many factors, including type
and complexity of surgical procedure, fixed versus variable
overhead costs, and the professional fees of the surgeon
and anesthesia provider [20]. It is estimated that operating
rooms cost, on average, US $62 min-1; ranging from as
low as US $22 to as high as US $133 min-1 [20]. The true
cost to the hospital is unpublished as institutions do not
typically openly disclose profit margins. These figures do
not account for implant costs and provider fees.
Provider fees vary based on means of compensation
from fixed salary to hourly wages. In a review of two
anesthesia departments in academic institutions, the hourly
staffing cost was found to range from US $111 to $176
with a median of $122 [21]. Though the pay per minute for
orthopaedic surgeons in the operating room is unpublished,
the median hourly pay of an orthopaedic surgeon in the
United States is $204–210 [22, 23]. Therefore, provider
fees would foreseeably cost another ($122 ? $204)/
60 min = $5 per minute to the hospital. Combined with
the cost of running the operating room for an additional
18.5 min, the long CMN would cost an additional
($62 ? $5) 9 18.5 min = $1248. These estimates are still
conservative as they do not include costs for other per-
sonnel including operating room and recovery nursing,
surgical technicians, other medical staff who may be
required to treat the effects of longer surgeries with more
blood loss, and the associated costs of increased blood
transfusions.
Finally, with regard to the differences in implant pricing,
at our institution the average long CMN costs roughly
$2400 while the short CMN costs $1800 (Depuy Synthes;
https://www.depuysynthes.com/). The cost of a long nail is
further increased by the additional locking screw ($230)
and reaming rod ($130). Altogether, considering the basic
pricing differences, locking screw, and reaming rod, a long
CMN costs approximately $960 more than a short nail.
Combining the aforementioned factors again yields a
conservative cost estimate of ($1248 ? $960) = $2208
more for utilization of a long CMN compared to a short
CMN.
Table 4 Long cephalomedullary nails (CMN) cost analysis (US $)
Contributing factors Cost Calculation Additional cost for long CMN
Operative time $62/min $62/min 9 (65.6–47.1 min) $1147
Provider fees
Orthopaedic surgeon $207/h ($329/h = $5.5/min) 9 (65.6–47.1 min) $101
Anesthesia $122/h
Total provider fee $329/h
Implant cost
Long CMN $2400 $(2400 - 1800) ? $230 ? $130 $960
Short CMN $1800
Additional locking screw $230
Reaming Rod $130
Total cost – $1147 ? $101 ? $960 $2208 (per long CMN)
Overall cost per reoperation – $2208 9 83 $183,264
Overall cost per refracture – $2208 9 154 $340,032
Average cost of reoperation $30,000 – –
Difference in cost for reoperation – $183,264/$30,000 6.1-fold
Difference in cost for refracture – $340,032/$30,000 11-fold
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Taking a number needed to treat to harm for refracture
of 154, assuming the refracture requires reoperation, the
total additional cost is ($2208 9 154 =) $340,032. Taking
the lower NNTH for all-cause reoperation (83), by the
same calculation we find an additional cost of $183,264 for
the long CMN. Therefore, whether considering reoperation
in general or reoperation only after refracture, the addi-
tional cost of long CMN is considerable.
This must be weighed against the cost of revision of a
periprosthetic fracture following use of a CMN. Revision
of a periprosthetic fracture is costly and not without
complication. However, the cost of revision surgery (re-
fixation or arthroplasty) for failure of primary fixation in
2014 was found to be on average $30,000 (revision hip
arthroplasty ranging from $20,000 to $40,000) [24–29].
This number pales into comparison to the added overall
cost of the long CMN, and this is based on a conservative
estimate. In addition, the charge to the patient could easily
be up to five- or six-fold this amount. Therefore, from a
cost-benefit analysis standpoint, the cost of using long
CMN over 154 cases represents roughly five- to ten-times
the cost of using short nails over the same period and
having one revision.
There are several other factors that favor short nails.
First, short nails are technically easier as the inter-lock
screws may be placed with the help of a jig. This allows
lower-volume surgeons to safely and efficiently lock the
nail distally. Second, short nails have demonstrably less
blood loss and need for transfusion [13, 14]. These factors
make short nails especially more attractive in the older
patient with multiple medical comorbidities. The cumu-
lative effect of these factors is not known. In addition,
given the findings of the power analysis, which demon-
strated that nearly 8500 patients would be needed to reach
true statistical significance, it is likely that the statistically
insignificant differences in refracture and reoperation rates
are not clinically significant to many orthopaedic
surgeons.
The primary limitation of this systematic review is the
limited power. A large multi-center database study would
be necessary to prove statistical significance for refracture
and reoperation rates. Given the increased blood loss,
operative time and fiscal cost associated with long com-
pared to short CMN, regardless of whether refracture or
reoperation rates are proven significantly higher by a better
powered analysis, there is still a role for the short CMN as
a faster, safer, less expensive, and less invasive option for
patients with an trochanteric femur fracture without sub-
trochanteric extension.
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